Literature DB >> 9490968

CT time-attenuation washout curves of adrenal adenomas and nonadenomas.

M Korobkin1, F J Brodeur, I R Francis, L E Quint, N R Dunnick, F Londy.   

Abstract

OBJECTIVE: The purpose of this study was to analyze the CT contrast enhancement washout curves of adrenal masses and to determine the earliest time after initial enhancement that differentiation of adenomas from nonadenomas is possible.
MATERIALS AND METHODS: Contrast enhancement washout curves were generated after delayed contrast-enhanced CT scans of 52 adrenal adenomas and 24 nonadenomas. The optimal threshold value and corresponding sensitivity and specificity for the diagnosis of adenoma were determined according to attenuation values. Also, we calculated the percentage and relative percentage of enhancement washout at time delays from 5 to 45 min after initial enhancement.
RESULTS: The mean percentage of enhancement washout for adrenal adenomas was 51% at 5 min and 70% at 15 min, compared with 8% and 20%, respectively, for nonadenomas. The sensitivity and specificity for the diagnosis of adenoma were both 96% at a threshold attenuation value of 37 H on the 15-min delayed enhanced scan.
CONCLUSION: On CT, adrenal adenomas show a much earlier and more rapid washout of contrast enhancement than do nonadenomas. Adenomas and nonadenomas can be differentiated by attenuation values or the percentage or relative percentage of washout as early as 5-15 min after enhancement.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9490968     DOI: 10.2214/ajr.170.3.9490968

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  54 in total

Review 1.  FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.

Authors:  Désirée Deandreis; Sophie Leboulleux; Caroline Caramella; Martin Schlumberger; Eric Baudin
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

2.  Images of pheochromocytoma in adrenal glands.

Authors:  Shaunagh McDermott; Colin J McCarthy; Michael A Blake
Journal:  Gland Surg       Date:  2015-08

3.  Utility of the 10 Hounsfield unit threshold for identifying adrenal adenomas: Can we improve?

Authors:  Michael J Kirsch; Miranda W Kohli; Kristin L Long; Susan C Pitt; David F Schneider; Rebecca S Sippel; Priya H Dedhia
Journal:  Am J Surg       Date:  2020-04-21       Impact factor: 2.565

Review 4.  Contemporary adrenal scintigraphy.

Authors:  Milton D Gross; Anca Avram; Lorraine M Fig; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-25       Impact factor: 9.236

5.  CT manifestations of adrenal trauma: experience with 73 cases.

Authors:  Alex O Sinelnikov; Hani H Abujudeh; David Chan; Robert A Novelline
Journal:  Emerg Radiol       Date:  2007-01-25

6.  The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.

Authors:  E Grossrubatscher; F Vignati; M Possa; P Lohi
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

7.  [Adrenal tumors: principles of imaging and differential diagnostics].

Authors:  C Degenhart
Journal:  Radiologe       Date:  2014-10       Impact factor: 0.635

8.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

9.  Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.

Authors:  Sung Hee Park; Myeong-Jin Kim; Joo Hee Kim; Joon Seok Lim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

Review 10.  The indeterminate adrenal lesion.

Authors:  Anju Sahdev; Jon Willatt; Isaac R Francis; Rodney H Reznek
Journal:  Cancer Imaging       Date:  2010-03-18       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.